EFDID: 151278EFD: View Filing

Issuer: Neurodyn Life Sciences Inc. (0001568852) - D

Accession: 0001140361-15-037869 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001568852
  • Entity Name:
    Neurodyn Life Sciences Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    BRITISH COLUMBIA, CANADA
  • Year of Inc:
    Over 5 years ago
  • Address:
    439 Helmcken Street
    VANCOUVER, A1 V6B 2E6
  • Other Issuers:
    Other Issuers 1
    Neurodyn Cognition Inc. (0001655923)
    Corporation, BRITISH COLUMBIA, CANADA
  • Persons:
    Related Persons 8
    Kenneth A. Cawkell
    Executive Officer, Director 
    Neurodyn Life Sciences Inc. and Neurodyn Cognition Inc.
    Denis G. Kay
    Executive Officer, Director 
    Neurodyn Life Sciences Inc.
    Robert L. Cervelli
    Director 
    Neurodyn Life Sciences Inc.
    James Mertz
    Director 
    Neurodyn Life Sciences Inc.
    Madolyn Mertz
    Director 
    Neurodyn Life Sciences Inc.
    Richard Devries
    Director 
    Neurodyn Life Sciences Inc.
    Len Mertz
    Director 
    Neurodyn Cognition Inc.
    Alfred Maelicke
    Director 
    Neurodyn Cognition Inc.
EDGAR: Offering Information
  • Accession Date:
    10/16/2015
  • First Sale Date:
    09/30/2015
  • Offering Amount:
    $650,000
  • Amount Sold:
    $650,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity, Units consisting of common shares of Neurodyn Life Sciences Inc. and Neurodyn Cognition Inc.
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Neurodyn Life Sciences Inc./s/ Kenneth A. CawkellKenneth A. CawkellChief Executive Officer2015-10-14
Neurodyn Cognition Inc./s/ Kenneth A. CawkellKenneth A. CawkellChief Executive Officer2015-10-14